Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 3
2021 1
2022 1
2023 3
2024 4
2025 4
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean petocz[au] (225 results)?
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.
Inomata M, Tsuda T, Ichikawa T, Matsumoto M, Mizushima I, Azechi K, Takata N, Murayama N, Hayashi K, Hirai T, Seto Z, Tokui K, Masaki Y, Taka C, Okazawa S, Kambara K, Imanishi S, Taniguchi H, Miwa T, Hayashi R, Matsui S, Tobe K. Inomata M, et al. Among authors: seto z. Thorac Cancer. 2023 Jun;14(17):1618-1623. doi: 10.1111/1759-7714.14907. Epub 2023 Apr 26. Thorac Cancer. 2023. PMID: 37101081 Free PMC article.
An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma.
Tsuda T, Ichikawa T, Matsumoto M, Mizusihima I, Azechi K, Takata N, Murayama N, Hayashi K, Hirai T, Seto Z, Tokui K, Masaki Y, Taka C, Okazawa S, Kambara K, Imanishi S, Taniguchi H, Miwa T, Hayashi R, Matsui S, Inomata M. Tsuda T, et al. Among authors: seto z. Discov Oncol. 2024 Aug 29;15(1):382. doi: 10.1007/s12672-024-01046-5. Discov Oncol. 2024. PMID: 39207576 Free PMC article.
Association Between the Severity of Immune-related Adverse Events and the Prognosis in Patients With Non-small Cell Lung Cancer Receiving Treatment With Immune Checkpoint Inhibitors.
Inomata M, Matsumoto M, Hayashi K, Seto Z, Hirai T, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Miwa T, Hayashi R, Matsui S, Tobe K. Inomata M, et al. Among authors: seto z. Anticancer Res. 2023 Jul;43(7):3241-3246. doi: 10.21873/anticanres.16498. Anticancer Res. 2023. PMID: 37351972
Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expression.
Inomata M, Minatoyama S, Takata N, Hayashi K, Hirai T, Seto Z, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Miwa T, Hayashi R, Matsui S, Tobe K. Inomata M, et al. Among authors: seto z. Mol Clin Oncol. 2024 May 1;20(6):43. doi: 10.3892/mco.2024.2741. eCollection 2024 Jun. Mol Clin Oncol. 2024. PMID: 38756869 Free PMC article.
Association of Tumor PD-L1 Expression With Time on Treatment Using EGFR-TKIs in Patients With EGFR-Mutant Non-small Cell Lung Cancer.
Inomata M, Matsumoto M, Mizushima I, Seto Z, Hayashi K, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Miwa T, Hayashi R, Matsui S, Tobe K. Inomata M, et al. Among authors: seto z. Cancer Diagn Progn. 2022 May 3;2(3):324-329. doi: 10.21873/cdp.10112. eCollection 2022 May-Jun. Cancer Diagn Progn. 2022. PMID: 35530643 Free PMC article.
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report.
Hirai T, Inomata M, Minatoyama S, Hashizume M, Takata N, Hayashi K, Seto Z, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Miwa T, Hayashi R, Tanaka S, Noguchi A, Sato T. Hirai T, et al. Among authors: seto z. In Vivo. 2024 May-Jun;38(3):1509-1511. doi: 10.21873/invivo.13599. In Vivo. 2024. PMID: 38688637 Free PMC article.
Multicenter Retrospective Analysis of Pulmonary Sarcomatoid Carcinoma Clinically Diagnosed Using Small Biopsy Specimens.
Inomata M, Tsuda T, Ichikawa T, Matsumoto M, Mizushima I, Azechi K, Takata N, Murayama N, Seto Z, Tokui K, Masaki Y, Okazawa S, Imanishi S, Miwa T, Hayashi R, Taniguchi H. Inomata M, et al. Among authors: seto z. Cancer Diagn Progn. 2025 May 3;5(3):363-369. doi: 10.21873/cdp.10448. eCollection 2025 May-Jun. Cancer Diagn Progn. 2025. PMID: 40322207 Free PMC article.
16 results